PIP-CIT ROUNDWORM SYRUP

Main information

  • Trade name:
  • PIP-CIT ROUNDWORM SYRUP
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • PIP-CIT ROUNDWORM SYRUP
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • BIRDS | CAT | DOG | DOG - PUPPY | KITTEN | AVIARY BIRD | BITCH | BREEDERS | BROILERS | BUDGERIGARS | CANARIES | CASTRATE | CAT -
  • Therapeutic area:
  • V15B + V15C
  • Therapeutic indications:
  • ROUNDWORM - ASCARIDIA SPP. | ROUNDWORM - TOXASCARIS LEONINA | ROUNDWORM - TOXOCARA CANIS | ASCARID | HUMAN INTESTINAL ROUNDWORM

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Cancelled
  • Authorization number:
  • 35678
  • Last update:
  • 09-08-2016

There are no safety alerts related to this product.

17-1-2019


Opinion/decision on a Paediatric investigation plan (PIP): Ferric pyrophosphate citrate, decision type: , therapeutic area: , PIP number: P/0263/2018

Opinion/decision on a Paediatric investigation plan (PIP): Ferric pyrophosphate citrate, decision type: , therapeutic area: , PIP number: P/0263/2018

Opinion/decision on a Paediatric investigation plan (PIP): Ferric pyrophosphate citrate, decision type: , therapeutic area: , PIP number: P/0263/2018

Europe - EMA - European Medicines Agency

28-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): Arimoclomol (citrate), decision type: , therapeutic area: , PIP number: P/0213/2018

Opinion/decision on a Paediatric investigation plan (PIP): Arimoclomol (citrate), decision type: , therapeutic area: , PIP number: P/0213/2018

Opinion/decision on a Paediatric investigation plan (PIP): Arimoclomol (citrate), decision type: , therapeutic area: , PIP number: P/0213/2018

Europe - EMA - European Medicines Agency

27-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): Potassium citrate monohydrated,potassium hydrogen carbonate (ADV7103), decision type: , therapeutic area: , PIP number: P/0214/2018

Opinion/decision on a Paediatric investigation plan (PIP): Potassium citrate monohydrated,potassium hydrogen carbonate (ADV7103), decision type: , therapeutic area: , PIP number: P/0214/2018

Opinion/decision on a Paediatric investigation plan (PIP): Potassium citrate monohydrated,potassium hydrogen carbonate (ADV7103), decision type: , therapeutic area: , PIP number: P/0214/2018

Europe - EMA - European Medicines Agency

27-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): Itacitinib, decision type: , therapeutic area: , PIP number: P/0208/2018

Opinion/decision on a Paediatric investigation plan (PIP): Itacitinib, decision type: , therapeutic area: , PIP number: P/0208/2018

Opinion/decision on a Paediatric investigation plan (PIP): Itacitinib, decision type: , therapeutic area: , PIP number: P/0208/2018

Europe - EMA - European Medicines Agency

22-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): Citric acid (as citric acid anhydrous) / sodium chloride / simeticone / macrogol 4000 / sodium citrate /sodium sulfate (as sodium sulfate anhydrous) / potassium chloride (PMF104), decision type:

Opinion/decision on a Paediatric investigation plan (PIP): Citric acid (as citric acid anhydrous) / sodium chloride / simeticone / macrogol 4000 / sodium citrate /sodium sulfate (as sodium sulfate anhydrous) / potassium chloride (PMF104), decision type:

Opinion/decision on a Paediatric investigation plan (PIP): Citric acid (as citric acid anhydrous) / sodium chloride / simeticone / macrogol 4000 / sodium citrate /sodium sulfate (as sodium sulfate anhydrous) / potassium chloride (PMF104), decision type: , therapeutic area: , PIP number: P/0223/2018

Europe - EMA - European Medicines Agency